States Move to License AI Doctors as FDA Steps Back

The rise of autonomous clinical chatbots tests the boundary between state medical licensure and federal device regulation, a development that affects how practitioners govern deployment, monitoring, and patient safety. According to PYMNTS, Utah launched the nation's first AI-powered prescription refill program in January, partnering with startup Doctronic to let a chatbot renew certain chronic medications; PYMNTS and the Associated Press report the pilot covers about 190 refillable drugs. STAT's May 11 opinion by Alon Bergman and a January Penn LDI briefing by Senior Fellow Bressman and co-authors both frame the FDA's current SaMD process as poorly matched to adaptive generative systems and propose licensure-style oversight. PYMNTS and The Verge report that security researchers were able to manipulate the Doctronic system to alter opioid dosing and generate misinformation, and PYMNTS/AP report Utah regulators voiced safety concerns after the pilot launched.